Control of bleeding, hemostasis, NARRATED animation1970-01-01T00:00:00+00:00Stages of hemostasis, clotting disorders and unwanted blood clot formation - thrombosis PT273Shttps://d38zjy0x98992m.cloudfront.net/c36f1d23-4b34-45c4-845c-d1f51f5a9cea/hemostasis_narrated_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/c36f1d23-4b34-45c4-845c-d1f51f5a9cea/hemostasis_narrated_mp4_hd_video.mp4

-- / 05:20hd

Anticoagulant drugs NARRATED animation

Overview of coagulation control. Mechanisms of action of heparin, low-molecular-weight heparin (LMWH), warfarin (vitamin K antagonist), and direct oral anticoagulants.

Duration: 05:20

Video resolution: 1920x1080 pixels @ 25.0 fps, ~1.8 Mbits/s

Anticoagulant drugs NARRATED animation2023-02-24T21:44:41ZOverview of coagulation control. Mechanisms of action of heparin, low-molecular-weight heparin (LMWH), warfarin (vitamin K antagonist), and direct oral anticoagulants.PT320Shttps://d38zjy0x98992m.cloudfront.net/1284b3a3-a4a2-4910-a479-581d1208e4d5/anticoagulants_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/1284b3a3-a4a2-4910-a479-581d1208e4d5/anticoagulants_mp4_hd_video.mp4

Pharmacology: Thrombolytic (Fibrinolytic) Drugs NARRATED Animation1970-01-01T00:00:00+00:00Thrombolytic therapy - mechanism of action. Fibrin-specific agents: tissue plasminogen activator (tPA), alteplase, reteplase, tenecteplase; and non–fibrin-specific agents: urokinase (uPA), streptokinase and anistreplase.PT248Shttps://d38zjy0x98992m.cloudfront.net/6357a9c8-f7dd-4a70-b4b9-66f0021fc9b4/thrombolytic_drugs_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/6357a9c8-f7dd-4a70-b4b9-66f0021fc9b4/thrombolytic_drugs_mp4_hd_video.mp4